Industry News
Pharmaceutical Industry News
The 2025 edition of Time’s…
The 2025 edition of Time’s annual “best inventions” list saw the magazine expand the docket from 200 to 300 innovations—more than 10% of which comprise medical devices, pharmaceuticals and other novel products in the healthcare
Auto-injector specialist Ypsomed…
Auto-injector specialist Ypsomed is hopping on the United States manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the first U.S. facility for
The Senate has passed a new…
The Senate has passed a new version of the Biosecure Act as part of an amendment to the National Defense Authorization Act for the upcoming fiscal year. While similar to last year's edition, this amendment
AstraZeneca and Daiichi Sankyo are…
AstraZeneca and Daiichi Sankyo are teeing up a TROP2 showdown with Gilead in first-line triple-negative breast cancer. China's InnoCare agreed to out-license three autoimmune candidates to Zenas. Lupin plans to invest $250 million to build
Pelthos Therapeutics is seeking…
Pelthos Therapeutics is seeking mothers who don’t mess around to raise awareness about the treatment of molluscum contagiosum.
Pharma representatives who…
Pharma representatives who received an invite to the summit have reportedly expressed “consternation” over the concern that the event’s host and guest list imply that the White House wants drugmakers to work with BlinkRx.
AstraZeneca has broken ground on a…
AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic development package for the project.
Eli Lilly has committed to setting…
Eli Lilly has committed to setting a new standard for onscreen representation of common chronic diseases, and it walked the walk with its recent sponsorship of a segment on “Project Runway.”
The FDA has approved Libtayo as…
The FDA has approved Libtayo as the first immunotherapy for adjuvant treatment of cutaneous squamous cell carcinoma. The nod applies to patients who are at a high risk of recurrence after surgery and radiation.
Lupin expects to invest a combined…
Lupin expects to invest a combined $250 million—covering R&D, infrastructure and capital expenditures over five years—to build a new pharmaceutical production plant in Coral Springs, Florida. The site will focus on the production of respiratory
Xspray has now received three FDA…
Xspray has now received three FDA complete response letters in as many years as it attempts to launch its Dasynoc, a leukemia med based on BMS' blockbuster Sprycel.
Phreesia’s Danielle Lynch…
Phreesia's Danielle Lynch discusses patient engagement at scale
Ferring plans to lay off 500…
Ferring plans to lay off 500 employees, or approximately 7% of its staff, as part of a streamlining effort, the company said in a brief statement.
How agentic AI is transforming…
How agentic AI is transforming market research in the pharmaceutical industry
AI-driven insights, patient…
AI-driven insights, patient support and omnichannel engagement key to future success
Wasserman says…
Wasserman says hyper-personalization and data-driven insights are reshaping pharma marketing
Eying a multiple sclerosis drug…
Eying a multiple sclerosis drug that it has tabbed with peak annual sales potential of $12 billion in the U.S. alone, Zenas BioPharma has struck a licensing deal with China-based InnoCare Pharma that could be
With a pair of new athletic…
With a pair of new athletic partnerships under its belt, Vanda Pharmaceuticals is suiting up as a multisport player.
The U.K. government is in…
The U.K. government is in "advanced talks" with the U.S. and aims to fend off potential tariffs by raising its standard cost-effectiveness threshold for new medicines, according to Politico.
Ahead of ESMO, Astellas shares its…
Ahead of ESMO, Astellas shares its vision to transform cancer care – bringing hope through science to patients living with the hardest-to-treat cancers